Lutz MW - Search Results

1

Neuromyelitis optica: Clinical course and potential prognostic indicators.

Masha N, Kimbrough DJ, Eckstein CP, Hudak NM, Skeen MB, Hartsell FL, Lutz MW, Shah S. Masha N, et al. Among authors: lutz mw. Mult Scler Relat Disord. 2023 Jan;69:104414. doi: 10.1016/j.msard.2022.104414. Epub 2022 Nov 19. Mult Scler Relat Disord. 2023. PMID: 36463620

2

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: Presentation and outcomes of adults at a single center.

Sutton P, Lutz MW, Hartsell FL, Kimbrough D, Tagg NT, Skeen M, Hudak NM, Eckstein C, Shah S. Sutton P, et al. Among authors: lutz mw. J Neuroimmunol. 2022 Dec 15;373:577987. doi: 10.1016/j.jneuroim.2022.577987. Epub 2022 Oct 14. J Neuroimmunol. 2022. PMID: 36272183

3

Study of "ALS reversals": LifeTime environmental exposures (StARLiTE).

Crayle J, Lutz M, Raymond J, Mehta P, Bedlack R. Crayle J, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Feb;24(1-2):54-62. doi: 10.1080/21678421.2022.2090846. Epub 2022 Jul 1. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 35775279

4

The Duke Myasthenia Gravis Clinic Registry: II. Analysis of outcomes.

Sanders DB, Lutz MW, Raja SM, Juel VC, Guptill JT, Hobson-Webb LD, Massey JM. Sanders DB, et al. Among authors: lutz mw. Muscle Nerve. 2023 Apr;67(4):291-296. doi: 10.1002/mus.27794. Epub 2023 Feb 20. Muscle Nerve. 2023. PMID: 36734303

5

Clenbuterol Treatment Is Safe and Associated With Slowed Disease Progression in a Small Open-Label Trial in Patients With Amyotrophic Lateral Sclerosis.

Li X, Koeberl DD, Lutz MW, Bedlack R. Li X, et al. Among authors: lutz mw. J Clin Neuromuscul Dis. 2023 Jun 1;24(4):214-221. doi: 10.1097/CND.0000000000000438. J Clin Neuromuscul Dis. 2023. PMID: 37219865

6

Characteristics of strokes associated with centrifugal flow left ventricular assist devices.

Inamullah O, Chiang YP, Bishawi M, Weiss M, Lutz MW, Blue LJ, Feng W, Milano CA, Luedke M, Husseini NE. Inamullah O, et al. Among authors: lutz mw. Sci Rep. 2021 Jan 18;11(1):1645. doi: 10.1038/s41598-021-81445-8. Sci Rep. 2021. PMID: 33462301 Free PMC article.

7

A longitudinal evaluation of fatigue in chronic inflammatory demyelinating polyneuropathy.

Gable KL, Peric S, Lutz MW, Bozovic I, Petrovic M, Stojanov A, Basta I, Allen JA. Gable KL, et al. Among authors: lutz mw. Brain Behav. 2022 Aug;12(8):e2712. doi: 10.1002/brb3.2712. Epub 2022 Jul 21. Brain Behav. 2022. PMID: 35862228 Free PMC article.

8

Suitability of Automated Writing Measures for Clinical Trial Outcome in Writer's Cramp.

Bukhari-Parlakturk N, Lutz MW, Al-Khalidi HR, Unnithan S, Wang JE, Scott B, Termsarasab P, Appelbaum LG, Calakos N. Bukhari-Parlakturk N, et al. Among authors: lutz mw. Mov Disord. 2023 Jan;38(1):123-132. doi: 10.1002/mds.29237. Epub 2022 Oct 13. Mov Disord. 2023. PMID: 36226903 Free PMC article.

9

Neuropsychological normative standards for late career physicians.

Koltai DC, Chin PE, Lutz MW, Bouvé VL, Taylor JW, Gualtieri AL, Morgenlander JC. Koltai DC, et al. Among authors: lutz mw. Clin Neuropsychol. 2024 Feb 29:1-17. doi: 10.1080/13854046.2024.2319899. Online ahead of print. Clin Neuropsychol. 2024. PMID: 38424449

10

Facilitation of motor evoked potentials after tetanic peripheral nerve stimulation.

Wehab Z, Lutz MW, Bell EP, Johnson HE, AlGaeed M, Husain AM. Wehab Z, et al. Among authors: lutz mw. Clin Neurophysiol. 2024 Jun;162:2-8. doi: 10.1016/j.clinph.2024.03.011. Epub 2024 Mar 18. Clin Neurophysiol. 2024. PMID: 38547586

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page